FIT-East

From Autumn 2019, faecal immunochemical tests (FITs) for use in primary care for patients whose symptoms suggest possible colorectal cancer, but do not represent a great enough risk of cancer for an urgent referral, have been rolled out in the East of England. FITs measure the amount of haemoglobin in a stool sample and can be used to identify possible colorectal cancer. Our FIT-East mixed methods pragmatic cohort study aims to determine this diagnostic accuracy and acceptability in these symptomatic primary care patients. It will also identify whether thresholds should differ between subgroups and assess the acceptability for primary care physicians and patients.

For more information please contact: Merel Pannebakker

FIT-International

Colorectal cancer is the third most common cancer in the UK and the second cause of cancer death. Because the symptoms of colorectal cancer are often vague and frequently related to benign ailments, colorectal cancer is often diagnosed at a late cancer stage, leaving little curative options. This study aims to review current worldwide recommendations around FIT use to triage patients with lower abdominal symptoms for suspected colorectal cancer in primary care. It will provide an overview of current guidelines and discuss the areas of uncertainty.

For more information please contact: Fiona Walter